NEFL and myeloid sarcoma: In contrast, data on blood NfL concentrations were based on the same test used by all five studies included resulting in a lesser degree of heterogeneity with a 0.47 (0.24–0.71) increase in MS (n = 1196) compared to controls (n = 660).